EODData

FRA, C5G: Orexo AB (publ)

07 Nov 2025
LAST:

2.340

CHANGE:
 0.10
OPEN:
2.340
HIGH:
2.340
ASK:
0.000
VOLUME:
400
CHG(%):
3.90
PREV:
2.435
LOW:
2.340
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 252.3402.3402.3402.340400
06 Nov 252.4352.4352.4352.435400
05 Nov 252.4002.4002.4002.400400
04 Nov 252.4552.4552.4552.455400
31 Oct 252.5352.5352.5352.535400
30 Oct 252.5552.5552.5402.540400
29 Oct 252.4052.5502.4052.550400
28 Oct 252.5552.5552.5552.5551.1K
27 Oct 252.5152.5602.5152.5601.1K
24 Oct 252.6952.6952.5202.5201.1K

COMPANY PROFILE

Name:Orexo AB (publ)
About:Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Sector:Healthcare
Address:Rapsgatan 7E, Uppsala, Sweden
Website:https://www.orexo.com
ISIN:SE0000736415
LEI:549300LJ5CCWDPTK9Z08

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.42 
Forward P/E:9.75 
PEG Ratio:-0.04 
Price to Sales:0.16 
Price to Book:-0.43 
Profit Margin:-0.37 
Operating Margin:-0.18 
Return on Assets:-0.16 
Return on Equity:1.61 
Revenue:49.38M 
EBITDA:5.32M 
Shares:34.51M 
Market Cap:80.74M 

TECHNICAL INDICATORS

MA5:2.434.0%
MA10:2.496.4%
MA20:3.0229.0%
MA50:2.5910.7%
MA100:2.187.5%
MA200:1.7831.3%
RSI14:14.94 
WPR14:-100.00 
MTM14:-1.24
ROC14:-0.35 
ATR:0.12 
Week High:2.548.3%
Week Low:2.340.0%
Month High:3.8363.5%
Month Low:2.3431.3%
Year High:3.8363.5%
Year Low:0.75211.2%